Last reviewed · How we verify
relief of acute bronchospasm — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Qvar Redihaler | BECLOMETHASONE | Norton Waterford | 2025-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Norton Waterford · 1 drug in relief of acute bronchospasm
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in relief of acute bronchospasm:
- relief of acute bronchospasm treatment updates — RSS
- relief of acute bronchospasm treatment updates — Atom
- relief of acute bronchospasm treatment updates — JSON
Cite this brief
Drug Landscape (2026). relief of acute bronchospasm — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/relief-of-acute-bronchospasm. Accessed 2026-06-10.
Related
- relief of acute bronchospasm full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing